Clinical Trials Logo
  1. Home
  2. Arterial Occlusive Diseases
  3. NCT00156611

Rio Trial - ReoPro and Peripheral Arterial Intervention to Improve Clinical Outcome in Patients With Peripheral Arterial Disease

Arterial Occlusive Diseases Clinical Trial

Official title:
ReoPro and Peripheral Arterial Intervention to Improve Clinical Outcome in Patients With Peripheral Arterial Disease – A Randomized Prospective Trial (RIO-Trial)

Clinical Trial Summary

The Rio Study is a randomized, double blinded German- Swiss- Austria multi-centre trial on the efficacy and safety of ReoPro together with interventional recanalization of TASC D lesions in the SFA and popliteal artery.

Clinical Trial Description

Purpose: The RIO trial is designed to test the efficacy of GP IIb/IIIa blockade on subacute reocclusions in patients with interventional recanalization of chronic occlusions in the superficial femoral and popliteal artery.

Methods: A total of 420 patients will be randomly assigned to ReoPro or placebo. Patients will be eligible for randomisation with occlusions longer than 5 cm. Doppler ultrasound follow-up will be at 30 days, and after 6, and 12 months. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00156611
Study type Interventional
Source University Hospital Tuebingen
Contact
Status Active, not recruiting
Phase Phase 2/Phase 3
Start date January 2002
Completion date December 2009
View Details
See also
  Status Clinical Trial Phase
Completed NCT03724279 - Crossing Atheroma or Thrombus With ByCross Device for Revascularization of Peripheral Arteries of Diameter ≥ 3mm N/A
Recruiting NCT04390672 - Multivessel TALENT N/A
Not yet recruiting NCT02841488 - Ischemic Pain Control With Analgesic Methods Clinical Trial Phase 3
Completed NCT00371371 - Intra-arterial Stem Cell Therapy for Patients With Chronic Limb Ischemia (CLI) Phase 1/Phase 2
Completed NCT00174759 - CASPAR : Clopidogrel and Acetyl Salicylic Acid in Bypass Surgery for Peripheral ARterial Disease Phase 3
Completed NCT00209443 - A Safety and Efficacy Clinical Study to Evaluate the Narrowing of the Aorto-iliac Arteries While Using Gadodiamide Phase 3
Completed NCT00000539 - Arterial Disease Multifactorial Intervention Trial (ADMIT) Phase 3
Recruiting NCT04089943 - The Role of microRNA-210 in Regulating Oxidative Stress in Patients With PAD N/A
Recruiting NCT04343209 - Ammonia N-13 Myocardial Blood Flow Absolute Quantification by PET in Patients With Known or Suspected CAD (Ammonia MAP)
Not yet recruiting NCT05930145 - Results of the Use of Two Stentrievers Simultaneosly Compared With One as a Primary Treatment in Acute Ischemic Stroke N/A
Recruiting NCT04142021 - Safety and Feasibility Evaluation of Planning and Execution of Surgical Revascularization Solely Based on Coronary CTA and FFRCT in Patients With Complex Coronary Artery Disease (FASTTRACK CABG)
Completed NCT03253692 - Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
Recruiting NCT04624854 - Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) Phase 4
Active, not recruiting NCT02921230 - Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery N/A
Recruiting NCT02593994 - IRIS-Onyx Cohort in the IRIS-DES Registry
Completed NCT02008097 - Clinical Benefits of B-Flow Ultrasound N/A
Terminated NCT01462721 - The eSVS® Mesh Randomized Post-Market Study N/A
Completed NCT00282646 - Safety and Feasibility Study of Autologous Bone Marrow Cell Transplantation in Patients With Peripheral Arterial Occlusive Disease (PAOD) Phase 2
Not yet recruiting NCT04956523 - Preliminary Tissue Monitoring During Endovascular Intervention Study
Recruiting NCT05616104 - FLEX FIRST Registry Research Protocol